Anhao Biotechnology (Guangdong) Co., Ltd. was established by Anhao Industrial Investment and is an innovative biotechnology enterprise focusing on the field of cardiovascular and cerebrovascular health. The company adheres to the concept of "preventing problems before they happen" and collaborates with well-known research laboratories in Chinese universities to build a complete industrial system from basic research, achievement transformation to health services around the prevention and management of cardiovascular and cerebrovascular diseases. It is committed to building a health defense line for billions of families through cutting-edge technology.
1、 Innovative drug research and development
Focusing on the key aspects of preventing cardiovascular and cerebrovascular diseases, we will collaborate with renowned research laboratories from Chinese universities to conduct research on natural active ingredients, explore their intervention effects on risk factors such as blood lipids and thrombosis, and develop safer and more effective targeted prevention and treatment plans.
2、 Biotechnology transformation
Promote the introduction and implementation of international cutting-edge biological research achievements, connect the transformation link from laboratory research to productization, quickly transform core technologies into preventive health products, and maximize the value of scientific research.
3、 Health Products and Services
Develop a product and service system that covers daily maintenance, functional foods, and health management for middle-aged and elderly people with high cardiovascular and cerebrovascular risks, providing scientific risk prevention and customized, scenario based health solutions.
